These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8364518)

  • 1. The development of oral vaccines based on live attenuated Salmonella strains.
    Chatfield S; Roberts M; Londono P; Cropley I; Douce G; Dougan G
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):1-7. PubMed ID: 8364518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live Salmonella as vaccines and carriers of foreign antigenic determinants.
    Chatfield SN; Strugnell RA; Dougan G
    Vaccine; 1989 Dec; 7(6):495-8. PubMed ID: 2481908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live oral avirulent Salmonella vaccines.
    Curtiss R; Kelly SM; Hassan JO
    Vet Microbiol; 1993 Nov; 37(3-4):397-405. PubMed ID: 8116195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella: immune responses and vaccines.
    Mastroeni P; Chabalgoity JA; Dunstan SJ; Maskell DJ; Dougan G
    Vet J; 2001 Mar; 161(2):132-64. PubMed ID: 11243685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens.
    Hormaeche CE
    J Immunol Methods; 1991 Aug; 142(1):113-20. PubMed ID: 1919015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
    Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
    Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.
    Fairweather NF; Chatfield SN; Makoff AJ; Strugnell RA; Bester J; Maskell DJ; Dougan G
    Infect Immun; 1990 May; 58(5):1323-6. PubMed ID: 2182542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suisaloral "Dessau"--a Salmonella cholerae suis live vaccine for oral, parenteral and combined applications].
    Schöll W; Grünert G
    Arch Exp Veterinarmed; 1980; 34(1):91-7. PubMed ID: 7416899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice].
    Ma F; Zou H; He Q
    Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1270-7. PubMed ID: 22126084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation.
    Linde K; Beer J; Bondarenko V
    Vaccine; 1990 Jun; 8(3):278-82. PubMed ID: 2194381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
    Cárdenas L; Clements JD
    Clin Microbiol Rev; 1992 Jul; 5(3):328-42. PubMed ID: 1498769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
    Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
    Abd El Ghany M; Jansen A; Clare S; Hall L; Pickard D; Kingsley RA; Dougan G
    Infect Immun; 2007 Apr; 75(4):1835-42. PubMed ID: 17296764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.